Who owns ASPIRE BIOPHARMA HLDGS INC WT EXP 021430?

Tip: Access positions for across all investors

Analyze quarterly positions in Aspire Biopharma Hldgs Inc Wt Exp 021430 with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aspire Biopharma Hldgs Inc Wt Exp 021430 stock

Who bought or sold ASPIRE BIOPHARMA HLDGS INC WT EXP 021430 this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Adage Capital Partners GP 1.1M $17k 0% Dec 2025
 View chart
Saba Capital Management 984k $19k 0% Dec 2025
 View chart
Linden Advisors 900k $18k 0% Dec 2025
 View chart
Aristeia Capital 682k $13k 0% Dec 2025
 View chart
Highbridge Capital Management 525k $8.7k -5% Dec 2025
 View chart
OZ Management 500k $9.8k 0% Dec 2025
 View chart
Verition Fund Management 433k $7.1k 0% Dec 2025
 View chart
Barclays 350k $5.8k 0% Dec 2025
 View chart
Millennium Management 275k $4.5k 0% Dec 2025
 View chart
Antara Capital 208k $3.4M 0% Dec 2025
 View chart
D. E. Shaw & Co 200k $3.3k 0% Dec 2025
 View chart
Wolverine Asset Management 197k $3.3k 0% Dec 2025
 View chart
Context Capital Management 175k $2.9k 0% Dec 2025
 View chart
Polar Securities 139k $2.7k 0% Dec 2025
 View chart
LMR Partners 125k $2.1k 0% Dec 2025
 View chart
Periscope Capital 125k $2.1k 0% Dec 2025
 View chart
Whitebox Advisors 119k $2.0k 0% Dec 2025
 View chart
VR Advisory Services 100k $1.6k 0% Dec 2025
 View chart
Limestone Investment Advisors 75k $1.2k 0% Dec 2025
 View chart
Picton Mahoney Asset Management 50k $825.000000 0% Dec 2025
 View chart
Blue Owl Capital Holdings 50k $1.0k 0% Dec 2025
 View chart
Crossingbridge Advisors 50k $822.459000 0% Dec 2025
 View chart
OMERS Administration Corporation 25k $412.500000 0% Dec 2025
 View chart
Mint Tower Capital Management B.V. 25k $132k 0% Dec 2025
 View chart
Athos Capital 21k $3.0k 100% Dec 2025
 View chart
Beacon Pointe Advisors 20k $330.000000 100% Dec 2025
 View chart
Flow Traders US 15k $0 -2% Dec 2025
 View chart
Advisor Group Holdings 50.00 $0 0% Dec 2025
 View chart
Investors Research Corp 10.00 $0 0% Mar 2026
 View chart

Who sold out of Aspire Biopharma Hldgs Inc Wt Exp 021430?

Fund or Company Name Date Sold Shares Held Valued At
Alberta Investment Management Corporation Sep 2025 250k $7.5k
Nomura Holdings Sep 2025 150k $4.5k
Susquehanna International Sep 2025 58k $1.7k